Schweizer, Christof <br/><br/>
Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.  [electronic resource] 

 -  Annals of hematology  Oct 2007 
 - 711-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1432-0584 
<br/><br/><label>Standard No.: </label>10.1007/s00277-007-0335-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Murine-Derived<br/>Autoantibodies--immunology<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunologic Factors--administration & dosage<br/>Male<br/>Middle Aged<br/>Platelet Count<br/>Platelet Membrane Glycoproteins--immunology<br/>Purpura, Thrombocytopenic, Idiopathic--blood<br/>Remission Induction<br/>Retrospective Studies<br/>Rituximab<br/>Splenectomy<br/>Time Factors